Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01938794 · ClinicalTrials.gov registry record

A New Approach to Measuring Energy Expenditure in Humans

A clinical trial of Human Energy Expenditure, sponsored by University of Colorado, Denver.

Completed
Registry status
72
Enrollment target
1
Study location

NCT01938794: Completed study of Human Energy Expenditure, sponsored by University of Colorado, Denver.

NCT01938794 is a study of Human Energy Expenditure that has completed, run by University of Colorado, Denver. The registered enrollment target is 72 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01938794, a study of Human Energy Expenditure, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
72 participants
Enrollment target
1
Study location

Study Summary

Accurately measuring how many calories a person burns each day is difficult to do. Researchers can do this with a technique called doubly labeled water (DLW). This involves drinking water that is "labeled" with a non-radioactive tracer. After a few hours, the labeled water can be detected in the urine. To measure how many calories are burned (Total daily energy expenditure, TDEE), urine samples are collected several days apart. Although this technique is accurate, it is also challenging for two reasons. First, the labeled water is expensive. Second, the urine samples are analyzed using equipment (Isotope Ratio Mass Spectrometer, or IRMS) that is expensive and difficult to operate. The goal of this project is to develop a new instrument to perform DLW measurements of TDEE. This instrument, called a triple isotope water analyzer (TIWA) is less expensive and easier to operate than IRMS. Additionally, since the TIWA is more accurate than IRMS, it may potentially reduce the amount of labeled water required to measure TDEE, and thus reduce costs. The purpose of this study is to compare the accuracy of measuring TDEE from labeled water using the new instrument (TIWA) and from the traditional approach (IRMS). We will also compare the accuracy to the measurement of TDEE from whole-room indirect calorimetry (metabolic room), which is considered the most accurate way to measure TDEE.

Conditions Studied

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2013-09
Est. Completion 2017-12-31
University of Colorado, Denver

1,283 total trials

What the finished NCT01938794 record still lists

NCT01938794 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.

The record links to 1 condition, with Human Energy Expenditure appearing as the primary indexed condition, and to 0 interventions.

NCT01938794 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT01938794 about?

NCT01938794 is a clinical study titled "A New Approach to Measuring Energy Expenditure in Humans". Accurately measuring how many calories a person burns each day is difficult to do. Researchers can do this with a technique called doubly labeled water (DLW). This involves drinking water that is "labeled" with a non-radioactive tracer. After a few hours, the labeled water can be detected in the uri...

What is the current status of trial NCT01938794?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2013-09. Estimated completion is 2017-12-31.

What conditions does trial NCT01938794 study?

This clinical trial studies the following conditions: Human Energy Expenditure.

Who is sponsoring clinical trial NCT01938794?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01938794 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01938794, the US trial registry maintained by the National Library of Medicine. NCT01938794 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.